GlassScriptPhysician profile
Adam R Brod
NPI 1326202177
$7,499.75
in general payments reported to CMS, 2019-2025
17 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $50.00 · 2021: $1,242 · 2022: $1,715 · 2023: $1,591 · 2024: $2,201 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,305 · Food and Beverage: $1,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,304.86 |
| Food and Beverage | $1,599.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prodigy Surgical Distribution, INC. | $2,793.38 | 2021-2024 | |
| Arthrex, INC. | $1,798.95 | 2022-2024 | |
| Lima USA, INC. | $1,442.00 | 2022 | |
| Zimmer Biomet Holdings, INC. | $350.47 | 2019-2024 | Comprehensive Shoulder System |
| Stryker Corporation | $242.11 | 2019-2024 | Gamma, Inspace, Conextions Tr Tendon Repair System-Implant Mechanism |
| Smith+Nephew, INC. | $146.82 | 2019 | |
| Arthrosurface Incorporated | $116.00 | 2019 | |
| Wright Medical Technology, INC. | $115.41 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $104.16 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $93.71 | 2023-2024 | Zilretta, Iovera, Exparel |
| Anika Therapeutics, INC. | $89.91 | 2022-2023 | Wristmotion |
| Endo USA, INC. | $61.68 | 2024-2025 | Xiaflex |
| Depuy Synthes Sales INC. | $49.74 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $28.88 | 2019-2023 | Xiaflex |
| Axogen | $28.40 | 2023 | Avance Nerve Graft |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap, INC. | $19.15 | 2024 | Cranioplate |
| Kowa Pharmaceuticals America, INC. | $18.98 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Brod listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.